The human MHC : evidence for multiple HLA-D-region genes.
暂无分享,去创建一个
R. Giles | C. Katovich Hurley | J. Donald Capra | Carolyn Katovich Hurley | Robert C. Giles | J. D. Capra
[1] F. Bach,et al. Dw/LD-related molecular polymorphism of DR4 β-chains , 1983, The Journal of experimental medicine.
[2] Xiaohong Wang,et al. Structural analysis of a human I-A homologue using a monoclonal antibody that recognizes an MB3-like specificity , 1983, The Journal of experimental medicine.
[3] E. Simpson,et al. The structure of a mutant H–2 gene suggests that the generation of polymorphism in H–2 genes may occur by gene conversion-like events , 1983, Nature.
[4] J. Woody,et al. SB-restricted presentation of influenza and herpes simplex virus antigens to human T-Iymphocyte clones , 1983, Nature.
[5] R. Winchester,et al. Association of Susceptibility to Certain Hematopoietic Malignancies with the Presence of la Allo(determinants Distinct from the DR Series; Utility of Monoclonal Antibody Reagents , 1983, Immunological reviews.
[6] J. Silver,et al. Antigen-presenting capabilities of human monocytes correlates with their expression of HLA-DS, an Ia determinant distinct from HLA-DR. , 1983, Journal of immunology.
[7] G. Ferrara,et al. Three Ia species with different structures and alloantigenic determinants in an HLA-homozygous cell line , 1983, The Journal of experimental medicine.
[8] D. Andrews,et al. A homozygous human cell line contains three subsets of HLA-DR-like antigens distinguishable by amino acid sequencing. , 1982, Biochemistry.
[9] Eric O Long,et al. Allelic polymorphism and complexity of the genes for HLA-DR β-chains—direct analysis by DNA–DNA hybridization , 1982, Nature.
[10] Eric O Long,et al. A molecular map of the immune response region from the major histocompatibility complex of the mouse , 1982, Nature.
[11] L. Nadler,et al. Alpha and beta chains of SB and DR antigens are structurally distinct , 1982, The Journal of experimental medicine.
[12] A. Moretta,et al. A monoclonal anti-DC1 antibody selectivity inhibits the generation of effector T cells mediating specific cytolytic activity , 1982, The Journal of experimental medicine.
[13] J. Strominger,et al. Direct evidence of homology between human DC-1 antigen and murine I-A molecules , 1982, Nature.
[14] W. Bodmer,et al. Sequence of an HLA-DR α-chain cDNA clone and intron-exon organization of the corresponding gene , 1982, Nature.
[15] E. Thorsby,et al. Antigen Presentation by Vascular Endothelial Cells and Epidermal Langerhans Cells: The Role of HLA‐DR , 1982, Immunological reviews.
[16] J. Kaufman,et al. HLA‐DR Antigens: Structure, Separation of Subpopulations, Gene Cloning and Function , 1982, Immunological reviews.
[17] R. Demars,et al. Serologic identification of the human secondary B cell antigens. Correlations between function, genetics, and structure , 1982, The Journal of experimental medicine.
[18] R. Tosi,et al. The Genetic Control of Human Ia Alloantigens: A Three‐Loci Model Derived from the Immunochemical Analysis of ‘Supertypic’ Specificities , 1982, Immunological reviews.
[19] E. Thorsby,et al. HLA‐D Region Molecules Restrict Proliferative T Cell Responses to Antigen , 1982, Immunological reviews.
[20] J. J. Rood,et al. HLA‐Linked Lymphocyte Activating Determinants , 1982 .
[21] Y. Koide,et al. The role of three distinct Ia-like antigen molecules in human T cell proliferative responses: effect of monoclonal anti-Ia-like antibodies. , 1982, Journal of immunology.
[22] S. Shaw,et al. Recognition of a polymorphic monocyte antigen in HLA , 1982, Nature.
[23] J. Silver,et al. Biochemical characterization of a second family of human Ia molecules, HLA-DS, equivalent to murine I-A subregion molecules , 1982, The Journal of experimental medicine.
[24] D. Larhammar,et al. Alpha chain of HLA-DR transplantation antigens is a member of the same protein superfamily as the immunoglobulins , 1982, Cell.
[25] Y. Sakiyama,et al. Association between the MB system and asthma in the Japanese. , 1982, Human immunology.
[26] F. Bach,et al. Five HLA-D clusters associated with HLA-DR4. , 1982, Human immunology.
[27] F. Bach,et al. Determinants not correlated with HLA-Dw, DR, or SB detected by primed lymphocyte typing. , 1982, Human immunology.
[28] P. Cresswell,et al. Human B cell alloantigens: expression of MB and MT determinants. , 1982, Journal of immunology.
[29] R. Karr,et al. Molecular relationships of the human B cell alloantigens, MT2, MB3, MT4, and DR5. , 1982, Journal of immunology.
[30] K. Ozato,et al. Detection of at least two distinct mouse I-E antigen molecules by the use of a monoclonal antibody. , 1982, Journal of immunology.
[31] C. Janeway,et al. Immune response gene function correlates with the expression of an Ia antigen. I. Preferential association of certain Ae and E alpha chains results in a quantitative deficiency in expression of an Ae:E alpha complex , 1982, The Journal of experimental medicine.
[32] J. Cerottini,et al. Allogeneic mixed lymphocyte reactions in humans: pretreatment of either the stimulator or the responder cell population with monoclonal anti-Ia antibodies leads to an inhibition of cell proliferation. , 1981, Journal of immunology.
[33] R. Tosi,et al. Human Ia molecules carrying DC1 determinants differ in both α- and β-subunits from Ia molecules carrying DR determinants , 1981 .
[34] J. Klein,et al. The traditional and a new version of the mouse H–2 complex , 1981, Nature.
[35] H. Orr,et al. Major histocompatibility antigens: The human (HLA-A,-B,-C) and murine (H-2K, H-2D) class I molecules , 1981, Cell.
[36] M. Crumpton,et al. MAJOR HISTOCOMPATIBILITY ANTIGENS , 1981 .
[37] L. Nadler,et al. Monoclonal antibodies defining serologically distinct HLA-D/DR related Ia-like antigens in man. , 1981, Human immunology.
[38] N. Matsuura,et al. Association of B cell alloantigen with juvenile onset diabetes mellitus in the Japanese. , 1980, Human immunology.
[39] P. Cresswell,et al. HLA-A2 as a target for cell-mediated lympholysis: evidence from immunoselected HLA-A2 negative mutant cell lines. , 1980, Human immunology.
[40] R. Cook,et al. Structural studies on the murine Ia alloantigens. VII. Further evidence for two-gene control of the E/C alloantigens. , 1980, Journal of immunology.
[41] V. Engelhard,et al. Induction of secondary cytotoxic T lymphocytes by liposomes containing HLA-DR antigens , 1980, Nature.
[42] J. D. Capra,et al. Organization of the immune response genes. , 1979, Science.
[43] H. Moutsopoulos,et al. Genetic differences between primary and secondary sicca syndrome. , 1979, The New England journal of medicine.
[44] T. Delovitch,et al. Evidence for two homologous, but nonidentical, Ia molecules determined by the I-EC subregion , 1979, The Journal of experimental medicine.
[45] P. Terasaki,et al. Evidence for a second B-cell locus separate from the DR locus. , 1978, Transplantation proceedings.
[46] R. Walford,et al. Studies of HLA alloantigens of the Navajo Indians of North America. I. Variance of association between HLA-DRW (WIA) and HLA-DW specificities. , 1978, Tissue antigens.
[47] J. Kaufman,et al. Purification and structural characterisation of human HLA-linked B-cell antigens , 1977, Nature.
[48] C. Scheffel,et al. Detection of non-HLA-DR determinants by alloreactive lymphocyte clones. , 1983, Human immunology.
[49] L R Pease,et al. Spontaneous H-2 mutants provide evidence that a copy mechanism analogous to gene conversion generates polymorphism in the major histocompatibility complex. , 1983, Proceedings of the National Academy of Sciences of the United States of America.
[50] P. Parham,et al. Histocompatibility antigens : structure and function , 1982 .
[51] J. Bodmer,et al. Two‐dimensional gel analysis of the polypeptides precipitated by a polymorphic HLA‐DR1,2,w6 monoclonal antibody: Evidence for a third locus , 1982, European journal of immunology.
[52] J. Woody,et al. Antigen-specific human T-lymphocyte clones. Genetic restriction of influenza virus-specific responses to HLA-D region genes. , 1982, Human immunology.
[53] H. Mcdevitt,et al. Detection of a common polypeptide chain in I--A and I--E sub-region immunoprecipitates. , 1979, Molecular immunology.